BACKGROUND: Early detection of changes in the glomerular filtration rate (GFR) is crucial in detecting acute kidney injury. There is burgeoning evidence from preclinical and clinical studies that symmetrical dimethylarginine (SDMA) correlates well with different parameters of renal function. In some studies, SDMA even outperformed creatinine as a marker of GFR. It is however unknown how fast SDMA is increasing after reduction in GFR. The aim of our study was therefore to determine the temporal change of SDMA in comparison with cystatin C after a defined reduction in GFR. METHODS: Blood samples from 24 healthy living-related kidney donors (19 F/5 M), mean age 55.2 ± 8.3 years, were collected prior to donation of the kidney as well as 1, 6, 12, 24, 72 and 168 h after unilateral nephrectomy. SDMA levels were measured using a liquid chromatography-mass spectrometry-based method. RESULTS: Within 6 h after unilateral nephrectomy, i.e. reduction of GFR by 50%, SDMA rose from 0.571 ± 0.120 to 0.659 ± 0.135 µmol/L (P < 0.001). Baseline cystatin C levels increased from 0.87 ± 0.16 to 1.07 ± 0.15 mg/L (P < 0.001). Also, serum creatinine rose significantly within 6 h after removal of one kidney from 65.4 ± 8.4 to 88.8 ± 10.2 µmol/L (P < 0.001). DISCUSSION: SDMA might be a valuable and early marker of change in GFR in the clinical and experimental setting. Future studies will have to clarify whether sensitivity, specificity and temporal resolution of SDMA make it an attractive candidate for the assessment of renal function in both the experimental and clinical setting.
BACKGROUND: Early detection of changes in the glomerular filtration rate (GFR) is crucial in detecting acute kidney injury. There is burgeoning evidence from preclinical and clinical studies that symmetrical dimethylarginine (SDMA) correlates well with different parameters of renal function. In some studies, SDMA even outperformed creatinine as a marker of GFR. It is however unknown how fast SDMA is increasing after reduction in GFR. The aim of our study was therefore to determine the temporal change of SDMA in comparison with cystatin C after a defined reduction in GFR. METHODS: Blood samples from 24 healthy living-related kidney donors (19 F/5 M), mean age 55.2 ± 8.3 years, were collected prior to donation of the kidney as well as 1, 6, 12, 24, 72 and 168 h after unilateral nephrectomy. SDMA levels were measured using a liquid chromatography-mass spectrometry-based method. RESULTS: Within 6 h after unilateral nephrectomy, i.e. reduction of GFR by 50%, SDMA rose from 0.571 ± 0.120 to 0.659 ± 0.135 µmol/L (P < 0.001). Baseline cystatin C levels increased from 0.87 ± 0.16 to 1.07 ± 0.15 mg/L (P < 0.001). Also, serum creatinine rose significantly within 6 h after removal of one kidney from 65.4 ± 8.4 to 88.8 ± 10.2 µmol/L (P < 0.001). DISCUSSION: SDMA might be a valuable and early marker of change in GFR in the clinical and experimental setting. Future studies will have to clarify whether sensitivity, specificity and temporal resolution of SDMA make it an attractive candidate for the assessment of renal function in both the experimental and clinical setting.
Authors: Yonghong Huan; Shiv Kapoor; Stephanie Deloach; Elizabeth Ommen; Kevin Meyers; Raymond R Townsend Journal: Am J Nephrol Date: 2013-08-27 Impact factor: 3.754
Authors: Nicole Lüneburg; Wolfgang Lieb; Tanja Zeller; Ming-Huei Chen; Renke Maas; Angela M Carter; Vanessa Xanthakis; Nicole L Glazer; Edzard Schwedhelm; Sudha Seshadri; Mohammad Arfan Ikram; William T Longstreth; Myriam Fornage; Inke R König; Christina Loley; Francisco M Ojeda; Arne Schillert; Thomas J Wang; Heinrich Sticht; Anja Kittel; Jörg König; Emelia J Benjamin; Lisa M Sullivan; Isabel Bernges; Maike Anderssohn; Andreas Ziegler; Christian Gieger; Thomas Illig; Christa Meisinger; H-Erich Wichmann; Philipp S Wild; Heribert Schunkert; Bruce M Psaty; Kerri L Wiggins; Susan R Heckbert; Nicholas Smith; Karl Lackner; Kathryn L Lunetta; Stefan Blankenberg; Jeanette Erdmann; Thomas Munzel; Peter J Grant; Ramachandran S Vasan; Rainer H Böger Journal: Circ Cardiovasc Genet Date: 2014-09-21
Authors: Tatjana Cvetković; Radmila Veličković-Radovanović; Dijana Stojanović; Nikola Stefanović; Aleksandra Ignjatović; Ivana Stojanović; Nikola Sladojević; Dušica Pavlović Journal: J Med Biochem Date: 2015-07-14 Impact factor: 3.402
Authors: D P Dahlem; R Neiger; A Schweighauser; T Francey; M Yerramilli; E Obare; S M L Steinbach Journal: J Vet Intern Med Date: 2017-03-30 Impact factor: 3.333
Authors: Jacek Rysz; Anna Gluba-Brzózka; Beata Franczyk; Zbigniew Jabłonowski; Aleksandra Ciałkowska-Rysz Journal: Int J Mol Sci Date: 2017-08-04 Impact factor: 5.923
Authors: Karsten Sydow; Christine Schmitz; Eike-Christin von Leitner; Robin von Leitner; Anna Klinke; Dorothee Atzler; Christian Krebs; Hartwig Wieboldt; Heimo Ehmke; Edzard Schwedhelm; Thomas Meinertz; Stefan Blankenberg; Rainer H Böger; Tim Magnus; Stephan Baldus; Ulrich Wenzel Journal: PLoS One Date: 2012-10-26 Impact factor: 3.240
Authors: Alexander Lukasz; Bodo Hoffmeister; Barbara Graf; Benno Wölk; Karsten Noeckler; Stefanie M Bode-Böger; Johannes Hadem; Sven Pischke; Jan T Kielstein Journal: PLoS One Date: 2014-01-30 Impact factor: 3.240
Authors: Anna Sandqvist; Jörn Schneede; David Kylhammar; Dan Henrohn; Jakob Lundgren; Mikael Hedeland; Ulf Bondesson; Göran Rådegran; Gerhard Wikström Journal: Heart Vessels Date: 2017-10-03 Impact factor: 2.037